Company: MDCXW
Filing Date: 2025-05-30
Form Type: 424B3
Source: 0001062993-25-010580
Chunk: 222

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-30
Form: 424B3
Chunk 222
---
. SkinJect incurred $270,419 of legal costs related to the RTO for the year ended December 31, 2023, included in general and administrative expense on the consolidated statements of loss and comprehensive loss. The consideration paid to acquire Interactive consisted of net liabilities assumed of $50,000, recognized directly in shareholder’s equity on completion of the RTO. Upon closing of the transaction, the Company assumed liabilities of $2,071,580 for costs incurred by RBx that related to the BCA and RTO. The assumed liabilities have been expensed and included in the line item 'general and administrative' in the statement of operations and comprehensive loss for the year ended December 31, 2023.

4. Balance sheet components Prepaid expenses include the following:

|                                 |   | Year ended December 31, 
                    2024 |     |   |    2023 |
|:--------------------------------|:--|------------------------:|:----|:--|--------:|
| Insurance                       | $ |                 583,561 |     | $ | 163,500 |
| Contract research organizations |   |                 455,810 |     |   |       - |
| Professional services           |   |                 144,643 |     |   |       - |
| Prepaid services                |   |                  29,970 |     |   |  10,219 |
|                                 | $ |               1,213,984 |     | $ | 173,719 |

F-15 Medicus Pharma Ltd.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2024 and 2023
[expressed in United States dollars, except share amounts] Accrued expenses and other current liabilities include the following:

|                                   |   | Year ended December 31, 
                    2024 |     |   |    2023 |
|:----------------------------------|:--|------------------------:|:----|:--|--------:|
| Accrued legal fees                | $ |                 495,016 |     | $ | 359,011 |
| Accrued compensation and benefits |   |                 140,989 |     |   |  27,766 |
| Accrued other                     |   |                 126,830 |     |   |  18,040 |
|                                   | $ |                 762,835 |     | $ | 404,817 |

5